Hims & Hers Health (HIMS) Current Assets (2019 - 2026)
Hims & Hers Health (HIMS) posted Current Assets of $1.0 billion for Q1 2026, up 36.18% sequentially from $767.6 million in Q4 2025, and up 133.88% YoY from $447.0 million in Q1 2025.
Hims & Hers Health (HIMS) Current Assets (2019 - 2026) Analysis & Trends
Hims & Hers Health has reported Current Assets for 8 years, with the latest figure at $1.0 billion in Q1 2026.
- Quarterly Current Assets rose 133.88% year-over-year to $1.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 billion (up 133.88% YoY) and the FY2025 annual result came in at $767.6 million, up 93.93% from the prior year.
- Current Assets grew to $1.0 billion in Q1 2026 per HIMS's latest filing, from $767.6 million in the prior quarter.
- Over five years, Current Assets peaked at $1.4 billion in Q2 2025 and troughed at $216.6 million in Q4 2022.
- A 5-year average of $448.4 million and a median of $265.1 million in 2023 frame the typical range for Current Assets.
- The sharpest annual moves came in 2022 and 2025: Current Assets plunged 31.82% in 2022, then soared 365.96% in 2025.
- Over 5 years, Current Assets stood at $216.6 million in 2022, then grew by 22.37% to $265.1 million in 2023, then jumped by 49.34% to $395.8 million in 2024, then surged by 93.93% to $767.6 million in 2025, then surged by 36.18% to $1.0 billion in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $1.0 billion, $767.6 million, and $845.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 3.22 Bn |
| 10 | Hims & Hers Health | 7.49 Bn | 6.65 Bn | 480.80 Mn | 1.38 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.38 Bn |
| Mar 31, 2026 | 1.05 Bn |
| Dec 31, 2025 | 767.64 Mn |
| Sep 30, 2025 | 845.26 Mn |
| Jun 30, 2025 | 1.36 Bn |
| Mar 31, 2025 | 446.96 Mn |
| Dec 31, 2024 | 395.83 Mn |
| Sep 30, 2024 | 326.38 Mn |
| Jun 30, 2024 | 290.92 Mn |
| Mar 31, 2024 | 261.73 Mn |
| Dec 31, 2023 | 265.05 Mn |
| Sep 30, 2023 | 250.22 Mn |
| Jun 30, 2023 | 234.65 Mn |
| Mar 31, 2023 | 225.53 Mn |
| Dec 31, 2022 | 216.60 Mn |
| Sep 30, 2022 | 233.46 Mn |
| Jun 30, 2022 | 230.49 Mn |
| Mar 31, 2022 | 231.95 Mn |
| Dec 31, 2021 | 269.91 Mn |
| Sep 30, 2021 | 274.23 Mn |